Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer.

Autor: Mehmeti-Ajradini M; Department of Translational Medicine, Cancer Immunology, Lund University, Malmö, Sweden., Bergenfelz C; Division of Experimental Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden., Larsson AM; Division of Oncology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Carlsson R; Translational Neurology, Department of Clinical Sciences and Wallenberg Centrum for Molecular Medicine, Lund University, Lund, Sweden., Riesbeck K; Department of Translational Medicine, Clinical Microbiology, Lund University, Malmö, Sweden., Ahl J; Department of Infectious Diseases, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Janols H; Department of Infectious Diseases, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Wullt M; Department of Infectious Diseases, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Bredberg A; Department of Translational Medicine, Clinical Microbiology, Lund University, Malmö, Sweden., Källberg E; Department of Translational Medicine, Cancer Immunology, Lund University, Malmö, Sweden., Björk Gunnarsdottir F; Department of Translational Medicine, Cancer Immunology, Lund University, Malmö, Sweden., Rydberg Millrud C; Department of Translational Medicine, Cancer Immunology, Lund University, Malmö, Sweden., Rydén L; Division of Oncology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.; Department of Surgery and Gastroenterology, Skåne University Hospital, Lund, Sweden., Paul G; Translational Neurology, Department of Clinical Sciences and Wallenberg Centrum for Molecular Medicine, Lund University, Lund, Sweden., Loman N; Division of Oncology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Adolfsson J; Science for Life Laboratory Node at Linköping's University, Linköping, Sweden., Carneiro A; Division of Oncology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Jirström K; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden., Killander F; Division of Oncology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Bexell D; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden., Leandersson K; Department of Translational Medicine, Cancer Immunology, Lund University, Malmö, Sweden Karin.Leandersson@med.lu.se.

Publikováno v: Life science alliance [Life Sci Alliance] 2020 Sep 21; Vol. 3 (11). Date of Electronic Publication: 2020 Sep 21 (Print Publication: 2020).